Home » KENDLE INTERNATIONAL OFFERS EXPANDED ACCESS TO CLINICAL TRIAL PATIENTS THROUGH NEW OPERATION IN INDIA
KENDLE INTERNATIONAL OFFERS EXPANDED ACCESS TO CLINICAL TRIAL PATIENTS THROUGH NEW OPERATION IN INDIA
Kendle, a leading, global full-service clinical research organization, today announced the opening of an office in New Delhi, India, further expanding its access to large patient populations in the Asia/Pacific region. The new location will provide full-service Phase I-IV clinical development solutions for biopharmaceutical companies conducting trials in India.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=18695120&full=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May